본문 바로가기
KERD
논문KCI 등재

Effects of Persisting Emotional Impact from Child Abuse and Norepinephrine Transporter Genetic Variation on Antidepressant Efficacy in Major Depression: A Pilot Study

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Objective: Previous studies suggest child abuse and serotonergic polymorphism influence depression susceptibility and antidepressant efficacy. Polymorphisms of the norepinephrine transporter (NET) may also be involved. Research in the area is possibly clouded by under reporting of abuse in researcher trials. Methods: Adults (n=51) with major depressive disorder has 8 weeks treatment with escitalopram or venlafaxine. Abuse history was obtained, the ongoing emotional impact of which was measured with the 15-item impact of event scale (IES-15). The 17-item Hamilton Depression Rating Scale (HDRS) was applied serially. Two NET polymorphisms (rs2242446 and rs5569) were assayed, blinded to HDRS ratings and abuse history. Results: No subjects reporting abuse with high impact in adulthood (IES-15 ≥26, n=12) remitted; whereas 77% reporting low impact (IES-15 <26; n=26) remitted (p<0.001). Subjects reporting high impact abuse (n=12) had a 50-fold (95% confidence interval=4.85-514.6) greater odds of carrying rs2242446-TT genotype, but the small sample size leaves this finding vulnerable to type I error. Conclusion: The level of persisting impact of child abuse appears relevant to antidepressant efficacy, with susceptibility to such possibly being influence by NET rs2242446 polymorphism. Larger studies may be merited to expand on this pilot level finding given potential for biomarker utility.

Abstract

Objective: Previous studies suggest child abuse and serotonergic polymorphism influence depression susceptibility and antidepressant efficacy. Polymorphisms of the norepinephrine transporter (NET) may also be involved. Research in the area is possibly clouded by under reporting of abuse in researcher trials. Methods: Adults (n=51) with major depressive disorder has 8 weeks treatment with escitalopram or venlafaxine. Abuse history was obtained, the ongoing emotional impact of which was measured with the 15-item impact of event scale (IES-15). The 17-item Hamilton Depression Rating Scale (HDRS) was applied serially. Two NET polymorphisms (rs2242446 and rs5569) were assayed, blinded to HDRS ratings and abuse history. Results: No subjects reporting abuse with high impact in adulthood (IES-15 ≥26, n=12) remitted; whereas 77% reporting low impact (IES-15 <26; n=26) remitted (p<0.001). Subjects reporting high impact abuse (n=12) had a 50-fold (95% confidence interval=4.85-514.6) greater odds of carrying rs2242446-TT genotype, but the small sample size leaves this finding vulnerable to type I error. Conclusion: The level of persisting impact of child abuse appears relevant to antidepressant efficacy, with susceptibility to such possibly being influence by NET rs2242446 polymorphism. Larger studies may be merited to expand on this pilot level finding given potential for biomarker utility.

참고문헌 (74)

  1. Dodd S., "Predictors of antidepressant response : A selective review", Int J Psychiatry Clin Pract, 8, pp.91~100 (2004)
  2. Kaplan MJ., "Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression", J Nerv Ment Dis, 188, pp.596~601 (2000)
  3. Nemeroff CB., "Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma", Proc Natl Acad Sci U S A, 100, pp.14293~14296 (2003)
  4. Enns MW., "Psychosocial and clinical predictors of symptom persistence vs remission in major depressive disorder", Can J Psychiatry, 50, pp.769~777 (2005)
  5. Johnstone JM., "Childhood neglect and abuse as predictors of antidepressant response in adult depression", Depress Anxiety, 26, pp.711~717 (2009)
  6. Klein DN., "Early adversity in chronic depression : clinical correlates and response to pharmacotherapy", Depress Anxiety, 26, pp.701~710 (2009)
  7. Miniati M., "Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse", J Psychiatr Res, 44, pp.302~309 (2010)
  8. Harkness KL., "Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder", J Consult Clin Psychol, 80, pp.342~353 (2012)
  9. Nanni V., "Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression : a meta-analysis", Am J Psychiatry, 169, pp.141~151 (2012)
  10. Conte JR., "Factors associated with an increased impact of child sexual abuse", Child Abuse Negl, 11, pp.201~211 (1987)
  11. Chaffin M., "Psychometric evaluation of the children's impact of traumatic events scale-revised", Child Abuse Negl, 25, pp.401~411 (2001)
  12. Hanson RF., "Factors related to the reporting of childhood rape", Child Abuse Negl, 23, pp.559~569 (1999)
  13. Roesler TA., "Telling the secret : adult women describe their disclosures of incest", J Interpers Violence, 9, pp.327~338 (1994)
  14. Roesler TA., "Reactions to disclosure of childhood sexual abuse. The effect on adult symptoms", J Nerv Ment Dis, 182, pp.618~624 (1994)
  15. McNulty C., "Adult disclosure of sexual abuse : a primary cause of psychological distress?", Child Abuse Negl, 18, pp.549~555 (1994)
  16. Everill J., "Disclosure of sexual abuse and psychological adjustment in female undergraduates", Child Abuse Negl, 19, pp.93~100 (1995)
  17. Ullman SE., "Social reactions to child sexual abuse disclosures : a critical review", J Child Sex Abus, 12, pp.89~121 (2003)
  18. Caspi A., "Genetic sensitivity to the environment : the case of the serotonin transporter gene and its implications for studying complex diseases and traits", Am J Psychiatry, 167, pp.509~527 (2010)
  19. Cicchetti D., "Resilience under conditions of extreme stress : a multilevel perspective", World Psychiatry, 9, pp.145~154 (2010)
  20. Cicchetti D., "The role of self-organization in the promotion of resilience in maltreated children", Dev Psychopathol, 9, pp.797~815 (1997)
  21. Cicchetti D., "A developmental psychopathology perspective on child abuse and neglect", J Am Acad Child Adolesc Psychiatry, 34, pp.541~565 (1995)
  22. Beeghly M., "Child maltreatment, attachment, and the self system : Emergence of an internal state lexicon in toddlers at high social risk", Dev Psychopathol, 6, pp.5~30 (1994)
  23. Haskett ME., "Diversity in adjustment of maltreated children : factors associated with resilient functioning", Clin Psychol Rev, 26, pp.796~812 (2006)
  24. Caspi A., "Influence of life stress on depression : moderation by a polymorphism in the 5-HTT gene", Science, 301, pp.386~389 (2003)
  25. Kaufman J., "Social supports and serotonin transporter gene moderate depression in maltreated children", Proc Natl Acad Sci U S A, 101, pp.17316~17321 (2004)
  26. Cicchetti D., "Interactions of child maltreatment and serotonin transporter and monoamine oxidase A polymorphisms : depressive symptomatology among adolescents from low socioeconomic status backgrounds", Dev Psychopathol, 19, pp.1161~1180 (2007)
  27. Risch N., "Interaction between the serotonin transporter gene(5-HTTLPR), stressful life events, and risk of depression : a meta-analysis", JAMA, 301, pp.2462~2471 (2009)
  28. Aguilera M., "Early adversity and 5-HTT", BDNF genes : new evidence of gene-environment interactions on depressive symptoms in a general population, 2009, pp.39, 1425~1432
  29. Aslund C., "Impact of the interaction between the 5HTTLPR polymorphism and maltreatment on adolescent depression. A population-based study", Behav Genet, 39, pp.524~531 (2009)
  30. Benjet C., "5-HTTLPR moderates the effect of relational peer victimization on depressive symptoms in adolescent girls", J Child Psychol Psychiatry, 51, pp.173~179 (2010)
  31. Kumsta R., "5HTT genotype moderates the influence of early institutional deprivation on emotional problems in adolescence : evidence from the English and Romanian Adoptee(ERA)study", J Child Psychol Psychiatry, 51, pp.755~762 (2010)
  32. Sugden K., "Serotonin transporter gene moderates the development of emotional problems among children following bullying victimization", J Am Acad Child Adolesc Psychiatry, 49, pp.830~840 (2010)
  33. Duncan LE., "A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry", Am J Psychiatry, 168, pp.1041~1049 (2011)
  34. Karg K., "The serotonin transporter promoter variant(5-HTTLPR), stress, and depression meta-analysis revisited : evidence of genetic moderation", Arch Gen Psychiatry, 68, pp.444~454 (2011)
  35. Danese A., "Adverse childhood experiences, allostasis, allostatic load, and age-related disease", Physiol Behav, 106, pp.29~39 (2012)
  36. De Bellis MD., "The biological effects of childhood trauma", Child Adolesc Psychiatr Clin N Am, 23, pp.185~222, vii (2014)
  37. Uher R., "Genes, environment, and individual differences in responding to treatment for depression", Harv Rev Psychiatry, 19, pp.109~124 (2011)
  38. Hirschfeld RM., "History and evolution of the monoamine hypothesis of depression", J Clin Psychiatry, 61(Suppl 6), pp.4~6 (2000)
  39. Strawn JR., "Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder", Depress Anxiety, 25, pp.260~271 (2008)
  40. Skelton K., "PTSD and gene variants : new pathways and new thinking", Neuropharmacology, 62, pp.628~637 (2012)
  41. De Bellis MD., "Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls", J Clin Endocrinol Metab, 78, pp.249~255 (1994)
  42. Girdler SS., "Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls", Psychosom Med, 65, pp.849~856 (2003)
  43. Lemieux AM., "Abuse-related posttraumatic stress disorder : evidence for chronic neuroendocrine activation in women", Psychosom Med, 57, pp.105~115 (1995)
  44. Uhl GR., "Neurotransmitter transporters : three important gene families for neuronal function", J Exp Biol, 196, pp.229~236 (1994)
  45. Amara SG., "Neurotransmitter transporters : recent progress", Annu Rev Neurosci, 16, pp.73~93 (1993)
  46. Béïque JC., "Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters", Eur J Pharmacol, 349, pp.129~132 (1998)
  47. Chen P., "Chronic social defeat up-regulates expression of norepinephrine transporter in rat brains", Neurochem Int, 60, pp.9~20 (2012)
  48. Kim CH., "A previously undescribed intron and extensive 5' upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene", J Biol Chem, 274, pp.6507~6518 (1999)
  49. Zill P., "Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression", Neuropsychopharmacology, 26, pp.489~493 (2002)
  50. Sogawa C., "Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6", PLoS One, 5, pp.e11945~ (2010)
  51. Higuchi H., "Milnacipran plasma levels and antidepressant response in Japanese major depressive patients", Hum Psychopharmacol, 18, pp.255~259 (2003)
  52. Yoshida K., "Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms", Am J Psychiatry, 161, pp.1575~1580 (2004)
  53. Kim H., "Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression", JAMA, 296, pp.1609~1618 (2006)
  54. Dong C., "Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2 : association with major depression and antidepressant response in Mexican-Americans", Mol Psychiatry, 14, pp.1105~1118 (2009)
  55. Belfer I., "Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations", J Hum Genet, 49, pp.232~245 (2004)
  56. Stöber G., "Systematic search for variation in the human norepinephrine transporter gene : identification of five naturally occurring missense mutations and study of association with major psychiatric disorders", Am J Med Genet, 67, pp.523~532 (1996)
  57. Singh AB., "ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression", Transl Psychiatry, 2, pp.e198~ (2012)
  58. Singh AB., "Psychomotor depressive symptoms may differentially respond to venlafaxine", Int Clin Psychopharmacol, 28, pp.121~126 (2013)
  59. Sundin EC., "Impact of Event Scale : psychometric properties", Br J Psychiatry, 180, pp.205~209 (2002)
  60. Berk M., "The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use", J Eval Clin Pract, 14, pp.979~983 (2008)
  61. Fries JF., "Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development", Arthritis Res Ther, 6, pp.R250~R255 (2004)
  62. Lingjaerde O., "The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients", Acta Psychiatr Scand Suppl, 334, pp.1~100 (1987)
  63. Porcelli S., "Pharmacogenetics of antidepressant response", J Psychiatry Neurosci, 36, pp.87~113 (2011)
  64. Gaunt TR., "Cubic exact solutions for the estimation of pairwise haplotype frequencies : implications for linkage disequilibrium analyses and a web tool 'CubeX'", BMC Bioinformatics, 8, pp.428~ (2007)
  65. Essex MJ., "Influence of early life stress on later hypothalamic-pituitary-adrenal axis functioning and its covariation with mental health symptoms : a study of the allostatic process from childhood into adolescence", Dev Psychopathol, 23, pp.1039~1058 (2011)
  66. Beach SR., "Methylation at SLC6A4 is linked to family history of child abuse: an examination of the Iowa Adoptee sample", Am J Med Genet B Neuropsychiatr Genet, 153B, pp.710~713 (2010)
  67. Kaffman A., "Neurodevelopmental sequelae of postnatal maternal care in rodents : clinical and research implications of molecular insights", J Child Psychol Psychiatry, 48, pp.224~244 (2007)
  68. Liu D., "Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress", Science, 277, pp.1659~1662 (1997)
  69. McGowan PO., "Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain", PLoS One, 3, pp.e2085~ (2008)
  70. McGowan PO., "Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse", Nat Neurosci, 12, pp.342~348 (2009)
  71. Schroeder M., "The epigenetic code in depression : implications for treatment", Clin Pharmacol Ther, 91, pp.310~314 (2012)
  72. Porcelli S., "Meta-analysis of serotonin transporter gene promoter polymorphism(5-HTTLPR)association with antidepressant efficacy", Eur Neuropsychopharmacol, 22, pp.239~258 (2012)
  73. Nierenberg AA., "Evolution of remission as the new standard in the treatment of depression", J Clin Psychiatry, 60(Suppl 22), pp.7~11 (1999)
  74. Zimmerman M., "Does the presence of one feature of borderline personality disorder have clinical significance? Implications for dimensional ratings of personality disorders", J Clin Psychiatry, 73, pp.8~12 (2012)

관련 논문AI추천

The Association Between Childhood Trauma and Selective Serotonin Reuptake Inhibitor Treatment Outcomes in Adult Patients With Major Depressive DisorderGang Wang, Gang Zhu, Hongjun Tian, Jing Wang, Jing Wei, Jingwen Sun, Kerang Zhang, Lijun Liu, Nan Zhang, Qiaoling Chen, Qi Liu, Shuzhe Zhou, Tianmei Si, Wen Bian, Xiaozhen Lv, Xin Yu, Xueyi Wang, Yutong Deng대한신경정신의학회 · PSYCHIATRY INVESTIGATION2025 · 제22권 제8호Interaction Effect of Childhood Abuse History and Suicidality on 12-Month Antidepressant Response in Patients With Depressive Disorder강희주, Il-Seon Shin, Jae-Min Kim, Ju-Wan Kim, Ju-Yeon Lee, Sung-Wan Kim, Ye-Jin Kim대한신경정신의학회 · PSYCHIATRY INVESTIGATION2024 · 제21권 제9호Impact of Early-Life Stress and Resilience on Patients with Major Depressive Disorder김원, 강은호, 석정호, 양종철, 이경욱, 이승환, 채정호, 함병주연세대학교의과대학 · Yonsei Medical Journal2012 · 제53권 제6호How Childhood Maltreatment Is Related to Suicidality, Bipolarity and Central Serotonergic Activity in Patients with Major Depressive Disorder: A Cross-Sectional Pilot StudyBun-Hee Lee, Young-Min Park대한신경정신의학회 · PSYCHIATRY INVESTIGATION2016 · 제13권 제2호Pharmacogenomic Study of Patients with Depression김도관, 임신원, Hyeran Kim대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2008 · 제6권 제1호Association between the 5-HTTLPR Genotype and Childhood Characteristics in Mood Disorders김세현, 방양원, 안용민, 은태경, 이규영, 정성훈, 주은정대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제1호

이 간행물의 다른 논문 (13건)